These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4064006)

  • 1. Genes and membrane signals involved in neoplastic transformation.
    Colburn NH
    Carcinog Compr Surv; 1985; 10():235-48. PubMed ID: 4064006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane and genetic events in tumor promotion: studies with promoter resistant variants of JB6 cells.
    Colburn NH; Lerman MI; Srinivas L; Nakamura Y; Gindhart TD
    Princess Takamatsu Symp; 1983; 14():155-66. PubMed ID: 6394588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genes that cooperate with tumor promoters in transformation.
    Colburn NH; Smith BM
    J Cell Biochem; 1987 Jun; 34(2):129-42. PubMed ID: 3597557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer by pro gene transfection of tumor promoter-sensitive phenotype to promotion-insensitive JB6 cells.
    Colburn NH; Smith BM; Wendel EJ; Dowjat WK; Shimada T
    Cancer Res; 1988 Mar; 48(5):1195-200. PubMed ID: 3342399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mouse pro-1 and pro-2 transfectants for responses to tumor promoters and antipromoters.
    Colburn NH; Smith BM; Wendel EJ; Nakamura Y; Winterstein D
    Cancer Res; 1988 Nov; 48(21):6076-80. PubMed ID: 3139288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses of preneoplastic epidermal cells to tumor promoters and growth factors: use of promoter-resistant variants for mechanism studies.
    Colburn NH; Wendel E; Srinivas L
    J Cell Biochem; 1982; 18(3):261-70. PubMed ID: 7068782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
    Jansen AP; Colburn NH; Verma AK
    Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of specific membrane and genetic changes in the mechanism of tumour promotion. Studies with promoter-resistant variants.
    Colburn NH; Srinivas L; Hegamyer GA; Dion LD; Wendel EJ; Cohen M; Gindhart TD
    IARC Sci Publ; 1984; (56):205-15. PubMed ID: 6536596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of genes associated with cell proliferation and apoptosis induced by okadaic acid during the transformation process of BALB/c 3T3 cells.
    Ao L; Liu JY; Gao LH; Liu SX; Yang MS; Huang MH; Cao J
    Toxicol In Vitro; 2008 Feb; 22(1):116-27. PubMed ID: 17935941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming JB6 cells exhibit enhanced integrin-mediated adhesion to osteopontin.
    Chang PL; Chambers AF
    J Cell Biochem; 2000 Apr; 78(1):8-23. PubMed ID: 10797562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adhesion, migration, transcriptional, interferon-inducible, and other signaling molecules newly implicated in cancer susceptibility and resistance of JB6 cells by cDNA microarray analyses.
    Samuel S; Bernstein LR
    Mol Carcinog; 2004 Jan; 39(1):34-60. PubMed ID: 14694446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin induction is required for tumor promoter-induced transformation of preneoplastic mouse cells.
    Chang PL; Cao M; Hicks P
    Carcinogenesis; 2003 Nov; 24(11):1749-58. PubMed ID: 12919959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.
    Watts RG; Huang C; Young MR; Li JJ; Dong Z; Pennie WD; Colburn NH
    Oncogene; 1998 Dec; 17(26):3493-8. PubMed ID: 10030673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
    DiGiovanni J; Rho O; Xian W; Beltràn L
    Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning of five messenger RNAs differentially expressed in preneoplastic or neoplastic JB6 mouse epidermal cells: one is homologous to human tissue inhibitor of metalloproteinases-3.
    Sun Y; Hegamyer G; Colburn NH
    Cancer Res; 1994 Mar; 54(5):1139-44. PubMed ID: 8118794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor promoter induces high mobility group HMG-Y protein expression in transformation-sensitive but not -resistant cells.
    Cmarik JL; Li Y; Ogram SA; Min H; Reeves R; Colburn NH
    Oncogene; 1998 Jul; 16(26):3387-96. PubMed ID: 9692546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 activation is required for interleukin-6 induced transformation in tumor-promotion sensitive mouse skin epithelial cells.
    Yu CY; Wang L; Khaletskiy A; Farrar WL; Larner A; Colburn NH; Li JJ
    Oncogene; 2002 Jun; 21(25):3949-60. PubMed ID: 12037677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element.
    Li JJ; Dong Z; Dawson MI; Colburn NH
    Cancer Res; 1996 Feb; 56(3):483-9. PubMed ID: 8564958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCH 51344 inhibits ras transformation by a novel mechanism.
    Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
    Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
    Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.